These findings demonstrated that dysregulation of the miR-30d–SOX4–PI3K-AKT axis is of great importance for the carcinogenesis of pancreatic cancer and might be a potential therapeutic target. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.